Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 93

    1.

    Antagonistic Effects of Aspirin and Folic Acid on Inflammation Markers and Subsequent Risk of Recurrent Colorectal Adenomas.

    Ho GY, Xue X, Cushman M, McKeown-Eyssen G, Sandler RS, Ahnen DJ, Barry EL, Saibil F, Bresalier RS, Rohan TE, Baron JA.

    J Natl Cancer Inst. 2009 Oct 12. [Epub ahead of print]PMID: 19822838 [PubMed - as supplied by publisher]Related articles

    2.

    Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial.

    Barry EL, Sansbury LB, Grau MV, Ali IU, Tsang S, Munroe DJ, Ahnen DJ, Sandler RS, Saibil F, Gui J, Bresalier RS, McKeown-Eyssen GE, Burke C, Baron JA.

    Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2726-33. Epub 2009 Sep 15.PMID: 19755647 [PubMed - in process]Related articles

    3.

    Using the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristics.

    Robertson DJ, Burke CA, Welch HG, Haile RW, Sandler RS, Greenberg ER, Ahnen DJ, Bresalier RS, Rothstein RI, Cole B, Mott LA, Baron JA.

    Ann Intern Med. 2009 Jul 21;151(2):103-9.PMID: 19620162 [PubMed - indexed for MEDLINE]Related articles

    4.

    Colonoscopy training for nurse endoscopists: is it possible? Is it wise? Is it worth doing?

    Ahnen DJ, Lieberman DA.

    Gastrointest Endosc. 2009 Mar;69(3 Pt 2):696-9. No abstract available. PMID: 19251012 [PubMed - indexed for MEDLINE]Related articles

    5.

    Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study.

    Grau MV, Sandler RS, McKeown-Eyssen G, Bresalier RS, Haile RW, Barry EL, Ahnen DJ, Gui J, Summers RW, Baron JA.

    J Natl Cancer Inst. 2009 Feb 18;101(4):267-76. Epub 2009 Feb 10.PMID: 19211442 [PubMed - indexed for MEDLINE]Related articles

    6.

    A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy.

    Martínez ME, Baron JA, Lieberman DA, Schatzkin A, Lanza E, Winawer SJ, Zauber AG, Jiang R, Ahnen DJ, Bond JH, Church TR, Robertson DJ, Smith-Warner SA, Jacobs ET, Alberts DS, Greenberg ER.

    Gastroenterology. 2009 Mar;136(3):832-41. Epub 2008 Dec 9.PMID: 19171141 [PubMed - indexed for MEDLINE]Related articles

    7.

    Association between body mass index and colorectal neoplasia at follow-up colonoscopy: a pooling study.

    Jacobs ET, Ahnen DJ, Ashbeck EL, Baron JA, Greenberg ER, Lance P, Lieberman DA, McKeown-Eyssen G, Schatzkin A, Thompson PA, Martínez ME.

    Am J Epidemiol. 2009 Mar 15;169(6):657-66. Epub 2009 Jan 15.PMID: 19147743 [PubMed - indexed for MEDLINE]Related articles

    8.

    Red meat and poultry intake, polymorphisms in the nucleotide excision repair and mismatch repair pathways and colorectal cancer risk.

    Joshi AD, Corral R, Siegmund KD, Haile RW, Le Marchand L, Martínez ME, Ahnen DJ, Sandler RS, Lance P, Stern MC.

    Carcinogenesis. 2009 Mar;30(3):472-9. Epub 2008 Nov 24.PMID: 19029193 [PubMed - indexed for MEDLINE]Related articles

    9.

    Targeting EGFR in colorectal cancer.

    Messersmith WA, Ahnen DJ.

    N Engl J Med. 2008 Oct 23;359(17):1834-6. No abstract available. PMID: 18946069 [PubMed - indexed for MEDLINE]Related articles

    10.

    Gastrin, Helicobacter pylori, and colorectal adenomas.

    Robertson DJ, Sandler RS, Ahnen DJ, Greenberg ER, Mott LA, Cole BF, Baron JA.

    Clin Gastroenterol Hepatol. 2009 Feb;7(2):163-7. Epub 2008 Sep 20.PMID: 18929688 [PubMed - indexed for MEDLINE]Related articles

    11.

    Colorectal adenomas in a randomized folate trial: the role of baseline dietary and circulating folate levels.

    Figueiredo JC, Levine AJ, Grau MV, Barry EL, Ueland PM, Ahnen DJ, Byers T, Bresalier RS, Summers RW, Bond J, McKeown-Eyssen GE, Sandler RS, Haile RW, Baron JA.

    Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2625-31.PMID: 18843003 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial.

    Meyskens FL Jr, McLaren CE, Pelot D, Fujikawa-Brooks S, Carpenter PM, Hawk E, Kelloff G, Lawson MJ, Kidao J, McCracken J, Albers CG, Ahnen DJ, Turgeon DK, Goldschmid S, Lance P, Hagedorn CH, Gillen DL, Gerner EW.

    Cancer Prev Res (Phila Pa). 2008 Jun;1(1):32-8.PMID: 18841250 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Stool DNA and occult blood testing for screen detection of colorectal neoplasia.

    Ahlquist DA, Sargent DJ, Loprinzi CL, Levin TR, Rex DK, Ahnen DJ, Knigge K, Lance MP, Burgart LJ, Hamilton SR, Allison JE, Lawson MJ, Devens ME, Harrington JJ, Hillman SL.

    Ann Intern Med. 2008 Oct 7;149(7):441-50, W81.PMID: 18838724 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Significance of serrated polyps of the colon.

    Groff RJ, Nash R, Ahnen DJ.

    Curr Gastroenterol Rep. 2008 Oct;10(5):490-8. Review.PMID: 18799125 [PubMed - indexed for MEDLINE]Related articles

    15.

    Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation.

    Figueiredo JC, Levine AJ, Grau MV, Midttun O, Ueland PM, Ahnen DJ, Barry EL, Tsang S, Munroe D, Ali I, Haile RW, Sandler RS, Baron JA.

    Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2136-45.PMID: 18708408 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening.

    DeBourcy AC, Lichtenberger S, Felton S, Butterfield KT, Ahnen DJ, Denberg TD.

    J Gen Intern Med. 2008 Feb;23(2):169-74. Epub 2007 Dec 21.PMID: 18157581 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Effect of orlistat on fecal fat, fecal biliary acids, and colonic cell proliferation in obese subjects.

    Ahnen DJ, Guerciolini R, Hauptman J, Blotner S, Woods CJ, Wargovich MJ.

    Clin Gastroenterol Hepatol. 2007 Nov;5(11):1291-9. Epub 2007 Oct 24.PMID: 17920338 [PubMed - indexed for MEDLINE]Related articles

    18.

    Five-year colon surveillance after screening colonoscopy.

    Lieberman DA, Weiss DG, Harford WV, Ahnen DJ, Provenzale D, Sontag SJ, Schnell TG, Chejfec G, Campbell DR, Kidao J, Bond JH, Nelson DB, Triadafilopoulos G, Ramirez FC, Collins JF, Johnston TK, McQuaid KR, Garewal H, Sampliner RE, Esquivel R, Robertson D.

    Gastroenterology. 2007 Oct;133(4):1077-85.PMID: 17698067 [PubMed - indexed for MEDLINE]Related articles

    19.

    Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.

    Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, McKeown-Eyssen G, Summers RW, Rothstein RI, Burke CA, Snover DC, Church TR, Allen JI, Robertson DJ, Beck GJ, Bond JH, Byers T, Mandel JS, Mott LA, Pearson LH, Barry EL, Rees JR, Marcon N, Saibil F, Ueland PM, Greenberg ER; Polyp Prevention Study Group.

    JAMA. 2007 Jun 6;297(21):2351-9.PMID: 17551129 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Effect of a mailed brochure on appointment-keeping for screening colonoscopy: a randomized trial.

    Denberg TD, Coombes JM, Byers TE, Marcus AC, Feinberg LE, Steiner JF, Ahnen DJ.

    Ann Intern Med. 2006 Dec 19;145(12):895-900.PMID: 17179058 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Clinical practice. Adenomatous polyps of the colon.

    Levine JS, Ahnen DJ.

    N Engl J Med. 2006 Dec 14;355(24):2551-7. Review. No abstract available. PMID: 17167138 [PubMed - indexed for MEDLINE]Related articles

    22.

    Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention.

    Barry EL, Baron JA, Bhat S, Grau MV, Burke CA, Sandler RS, Ahnen DJ, Haile RW, O'Brien TG.

    J Natl Cancer Inst. 2006 Oct 18;98(20):1494-500. Erratum in: J Natl Cancer Inst. 2006 Dec 20;98(24):1828. PMID: 17047198 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics.

    Einspahr JG, Martinez ME, Jiang R, Hsu CH, Rashid A, Bhattacharrya AK, Ahnen DJ, Jacobs ET, Houlihan PS, Webb CR, Alberts DS, Hamilton SR.

    Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1443-50. Erratum in: Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):2016. Rashid, Asif [added]. PMID: 16896030 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Sulindac independently modulates extracellular signal-regulated kinase 1/2 and cyclic GMP-dependent protein kinase signaling pathways.

    Rice PL, Peters SL, Beard KS, Ahnen DJ.

    Mol Cancer Ther. 2006 Mar;5(3):746-54.PMID: 16546990 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Predictors of nonadherence to screening colonoscopy.

    Denberg TD, Melhado TV, Coombes JM, Beaty BL, Berman K, Byers TE, Marcus AC, Steiner JF, Ahnen DJ.

    J Gen Intern Med. 2005 Nov;20(11):989-95.PMID: 16307622 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Randomized, placebo-controlled, esophageal squamous cell cancer chemoprevention trial of selenomethionine and celecoxib.

    Limburg PJ, Wei W, Ahnen DJ, Qiao Y, Hawk ET, Wang G, Giffen CA, Wang G, Roth MJ, Lu N, Korn EL, Ma Y, Caldwell KL, Dong Z, Taylor PR, Dawsey SM.

    Gastroenterology. 2005 Sep;129(3):863-73.PMID: 16143126 [PubMed - indexed for MEDLINE]Related articles

    27.

    Sulindac metabolites inhibit epidermal growth factor receptor activation and expression.

    Pangburn HA, Kraus H, Ahnen DJ, Rice PL.

    J Carcinog. 2005 Sep 2;4:16.PMID: 16138927 [PubMed]Related articlesFree article

    28.

    beta-Catenin splice variants and downstream targets as markers for neoplastic progression of esophageal cancer.

    Roth MJ, Hu N, Johnson LL, Quon-Hang W, Ahnen DJ, Iwamoto M, Dawsey SM, Taylor PR, Huppi K.

    Genes Chromosomes Cancer. 2005 Dec;44(4):423-8.PMID: 16114033 [PubMed - indexed for MEDLINE]Related articles

    29.

    Histamine receptor antagonists and incident colorectal adenomas.

    Robertson DJ, Burke CA, Schwender BJ, Wargovich MJ, Greenberg ER, Sandler RS, Ahnen DJ, Rothstein R, Mott LA, Baron JA.

    Aliment Pharmacol Ther. 2005 Jul 15;22(2):123-8.PMID: 16011670 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Nuclear accumulation of beta-catenin occurs commonly in the epithelial cells of juvenile polyps.

    Iwamoto M, Hoffenberg EJ, Carethers JM, Doctolero R, Tajima A, Sugano K, Franklin WA, Ahnen DJ.

    Pediatr Res. 2005 Jan;57(1):4-9; discussion 1-3. Epub 2004 Nov 19.PMID: 15557107 [PubMed - indexed for MEDLINE]Related articles

    31.

    Inhibition of extracellular-signal regulated kinases 1/2 is required for apoptosis of human colon cancer cells in vitro by sulindac metabolites.

    Rice PL, Beard KS, Driggers LJ, Ahnen DJ.

    Cancer Res. 2004 Nov 15;64(22):8148-51.PMID: 15548677 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Measures for ascertaining use of colorectal cancer screening in behavioral, health services, and epidemiologic research.

    Vernon SW, Meissner H, Klabunde C, Rimer BK, Ahnen DJ, Bastani R, Mandelson MT, Nadel MR, Sheinfeld-Gorin S, Zapka J.

    Cancer Epidemiol Biomarkers Prev. 2004 Jun;13(6):898-905. No abstract available. PMID: 15184243 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    First-degree relatives of patients with advanced colorectal adenomas have an increased prevalence of colorectal cancer.

    Lynch KL, Ahnen DJ, Byers T, Weiss DG, Lieberman DA.

    Clin Gastroenterol Hepatol. 2003 Mar;1(2):96-102.PMID: 15017501 [PubMed - indexed for MEDLINE]Related articles

    34.

    Sulindac metabolites induce caspase- and proteasome-dependent degradation of beta-catenin protein in human colon cancer cells.

    Rice PL, Kelloff J, Sullivan H, Driggers LJ, Beard KS, Kuwada S, Piazza G, Ahnen DJ.

    Mol Cancer Ther. 2003 Sep;2(9):885-92.PMID: 14555707 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Sulindac sulfide inhibits epidermal growth factor-induced phosphorylation of extracellular-regulated kinase 1/2 and Bad in human colon cancer cells.

    Rice PL, Washington M, Schleman S, Beard KS, Driggers LJ, Ahnen DJ.

    Cancer Res. 2003 Feb 1;63(3):616-20.PMID: 12566304 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Ki-ras proto-oncogene mutations in sporadic colorectal adenomas: relationship to histologic and clinical characteristics.

    Maltzman T, Knoll K, Martinez ME, Byers T, Stevens BR, Marshall JR, Reid ME, Einspahr J, Hart N, Bhattacharyya AK, Kramer CB, Sampliner R, Alberts DS, Ahnen DJ.

    Gastroenterology. 2001 Aug;121(2):302-9.PMID: 11487539 [PubMed - indexed for MEDLINE]Related articles

    37.

    Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites.

    Rice PL, Goldberg RJ, Ray EC, Driggers LJ, Ahnen DJ.

    Cancer Res. 2001 Feb 15;61(4):1541-7.PMID: 11245463 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Colorectal cancer screening in average- and high-risk groups.

    Ahnen DJ, Lynch KL.

    Adv Intern Med. 2001;46:77-106. Review. No abstract available. PMID: 11147261 [PubMed - indexed for MEDLINE]Related articles

    39.

    Expression of beta-catenin and full-length APC protein in normal and neoplastic colonic tissues.

    Iwamoto M, Ahnen DJ, Franklin WA, Maltzman TH.

    Carcinogenesis. 2000 Nov;21(11):1935-40.PMID: 11062151 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Colorectal cancer survival in Europe: the Will Rogers phenomenon revisited.

    Shahrier M, Ahnen DJ.

    Gut. 2000 Oct;47(4):463-4. No abstract available. PMID: 10986203 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380.

    Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G.

    N Engl J Med. 2000 Jul 20;343(3):162-8. Erratum in: N Engl J Med 2000 Oct 19;343(16):1204. PMID: 10900274 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Risk factors for Ki-ras protooncogene mutation in sporadic colorectal adenomas.

    Martínez ME, Maltzman T, Marshall JR, Einspahr J, Reid ME, Sampliner R, Ahnen DJ, Hamilton SR, Alberts DS.

    Cancer Res. 1999 Oct 15;59(20):5181-5.PMID: 10537295 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Tissue markers of colon cancer risk.

    Ahnen DJ.

    Gastrointest Endosc. 1999 Mar;49(3 Pt 2):S50-9. Review. No abstract available. PMID: 10049449 [PubMed - indexed for MEDLINE]Related articles

    44.

    Colon cancer prevention by NSAIDs: what is the mechanism of action?

    Ahnen DJ.

    Eur J Surg Suppl. 1998;(582):111-4. Review.PMID: 10029375 [PubMed - indexed for MEDLINE]Related articles

    45.

    Symptomatic colonic polyps in childhood: not so benign.

    Hoffenberg EJ, Sauaia A, Maltzman T, Knoll K, Ahnen DJ.

    J Pediatr Gastroenterol Nutr. 1999 Feb;28(2):175-81.PMID: 9932851 [PubMed - indexed for MEDLINE]Related articles

    46.

    Variable phenotype of familial adenomatous polyposis in pedigrees with 3' mutation in the APC gene.

    Brensinger JD, Laken SJ, Luce MC, Powell SM, Vance GH, Ahnen DJ, Petersen GM, Hamilton SR, Giardiello FM.

    Gut. 1998 Oct;43(4):548-52.PMID: 9824584 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Proliferation happens.

    Ahnen DJ, Byers T.

    JAMA. 1998 Sep 23-30;280(12):1095-6. No abstract available. PMID: 9757861 [PubMed - indexed for MEDLINE]Related articles

    48.

    Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumor formation by FGN-1 (sulindac sulfone).

    Malkinson AM, Koski KM, Dwyer-Nield LD, Rice PL, Rioux N, Castonguay A, Ahnen DJ, Thompson H, Pamukcu R, Piazza GA.

    Carcinogenesis. 1998 Aug;19(8):1353-6.PMID: 9744528 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.

    Ahnen DJ, Feigl P, Quan G, Fenoglio-Preiser C, Lovato LC, Bunn PA Jr, Stemmerman G, Wells JD, Macdonald JS, Meyskens FL Jr.

    Cancer Res. 1998 Mar 15;58(6):1149-58.PMID: 9515799 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    A K-ras oncogene increases resistance to sulindac-induced apoptosis in rat enterocytes.

    Arber N, Han EK, Sgambato A, Piazza GA, Delohery TM, Begemann M, Weghorst CM, Kim NH, Pamukcu R, Ahnen DJ, Reed JC, Weinstein IB, Holt PR.

    Gastroenterology. 1997 Dec;113(6):1892-900.PMID: 9394728 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...